Brief: Simris Announces Positive Results From Study With Nuvisan
05/11/2025 12:03
Nov 5 (Reuters) - Simris Group AB SIMRISb.ST: ANNOUNCES POSITIVE RESULTS FROM ONGOING ANTIBODY-DRUG CONJUGATE (ADC) STUDY WITH NUVISAN SIMRIS-121 TO PROCEED TO NEXT STAGE OF NUVISAN STUDY DOSE-ESCALATION IN-VIVO STUDY TO DETERMINE MTD OF ADC IN MICE Source text: ID:nMFN3bllp0 Further company coverage: [SIMRISb.ST] (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))